Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p>The <em>Dang-Gui-Si-Ni</em> (DGSN) decoction as a classic prescription has been widely used for thousands of years in the clinical practice of traditional Chinese medicine (TCM). Especially in recent years, the potential efficacy of TCM for the treatment of Raynaud's syndrome has attracted great attention as there are still no specific remedies for this disease. However, the active constituents and underlying mechanisms responsible for the therapeutic benefits are not well understood, which makes it difficult to ensure quality control or to design research and drug development strategies. To identify the potential pharmacodynamic ingredients (PPIs) of TCM will help to achieve suitable process control procedures for industrial production and large-scale manufacturing.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aim of the study</h3><p>In the present study, we propose a multi-dimensional qualitative analysis method combining water-decoction spectra, <em>in-vitro</em> intestinal absorption spectra, <em>in-vivo</em> plasma spectra, and molecular docking of components to quickly identify the PPIs for the DGSN decoction of TCM.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>Water-based decoctions of DGSN were prepared in accordance with the clinical use registered in ancient books. Ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry (UHPLC-Q/TOF-MS) coupled with computerized modelling activity screening was used to quickly identify the PPIs of the DGSN decoction. Bioactive compounds absorbed <em>in vitro</em> were identified using the everted intestinal sac model from rats and compounds absorbed <em>in vivo</em> were confirmed in portal vein blood samples obtained following oral administration in rats. Molecular docking validation experiments were adopted to predict the binding activity to coagulation factors I, II, VII, X, and IX. The active components were further confirmed by pharmacodynamics analysis. The anticoagulant activity of the DGSN decoction was verified using rat models.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Thirty-one compounds were identified in the DGSN decoction. According to the <em>in vivo</em> experiments, 22 compounds that could be absorbed <em>in vivo</em> were detected by the everted intestinal sac model in rats. This model greatly reduces the scope of PPIs and is easy to perform. Ten compounds were detected in the portal vein blood in rats. The compounds detected in plasma provide stronger evidence supporting the PPIs. Molecular docking <em>in vitro</em> experiments indicated that 7 compounds exhibited better binding activity with coagulation factors I, II, VII, X, and IX. The animal experiments confirmed that the DGSN decoction could improve the microcirculation, providing indirect proof of anticoagulant activity suggested by the molecular docking studies. Finally, based on the multi-dimensional methods, 9 potential compounds present in the DGSN decoction were identified as PPIs (i.e., ferulic acid, paeoniflorin, albiflorin, chlorogenic acid, cryptochlorogenic acid, liquiritin, liquiritin apioside, cinnamaldehyde and glycyrrhizic acid).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Overall, this study combined the water-decoction spectra, intestinal absorption spectra <em>in vitro</em>, plasma spectra <em>in vivo,</em> and molecular docking studies to establish a multi-dimensional qualitative analysis method of the DGSN decoction. Meanwhile, 9 compounds in DGSN decoction were identified as PPIs using this method, and are proposed for application as quality standards for complex TCM prescriptions.</p>

Progresses:Constituents and Pharmacological Analyses of Guan Xin Er Hao Decoction

Characterization of Chemical Constituents in Guan Xin II Decoction by Liquid Chromatography Coupled with Electrospray Ionization-Mass Spectrometry.

Qualitative and Quantitative Analysis of the Chemical Profile for Gualou-Xiebai-Banxia Decoction, a Classical Traditional Chinese Medicine Formula for the Treatment of Coronary Heart Disease, by UPLC-Q/TOF-MS Combined with Chemometric Analysis

Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction

Systematic chemical characterization of Xiexin decoctions using high performance liquid chromatography coupled with electrospray ionization mass spectrometry

[Review of chemical constituents,pharmacological effects and clinical applications of Danggui Buxue Decoction and prediction and analysis of its Q-markers]

Pharmacokinetic Study of Eight Bioactive Components Following Oral Administration of Zhiqiao Gancao Decoction and Observation of Its Clinical Efficacy.

[Research progress on Huangqi Guizhi Wuwu Decoction and predictive analysis of quality markers]

Metabolic Profiling Of Guanxin Ii Prescription Based On Metabolic Fingerprinting And Chemical Analysis

Banxia Xiexin decoction: A review on phytochemical, pharmacological, clinical and pharmacokinetic investigations

Chemical profiling and quality evaluation of Zhishi-Xiebai-Guizhi Decoction by UPLC-Q-TOF-MS and UPLC fingerprint

Rapid identification, quantitation, and antioxidant activity evaluation of the components in Guanxin Shutong capsule with liquid chromatography and mass spectrometry

Identification of chemical constituents in vitro and in vivo of Er Shen Zhenwu Decoction by utilizing ultra-high-performance liquid chromatography with quadrupole time-of-flight mass spectrometry

[Progress on historical evolution, clinical application, and pharmacological effects of Dachaihu Decoction and predictive analysis of its quality markers]

Identification of the Major Constituents in Shi-Quan-Da-Bu Decoction by HPLC-ESI-MS/MS

Integrated pharmacokinetic properties and tissue distribution of multiple active constituents in Qing-Yi Recipe: A comparison between granules and decoction

Kinetic features of Gualou-Xiebai-Banxia decoction, a classical traditional Chinese medicine formula, in rat plasma and intestine content based on its metabolic profile

The integrated study on the chemical profiling and in vivo course to explore the bioactive constituents and potential targets of Chinese classical formula Qingxin Lianzi Yin Decoction by UHPLC-MS and network pharmacology approaches

Metabolites profile of Gualou Xiebai Baijiu decoction (a classical traditional Chinese medicine prescription) in rats by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry

Comparative in vivo constituents and pharmacokinetic study in rats after oral administration of ultrafine granular powder and traditional decoction slices of Chinese Salvia

Discovery of potential pharmacodynamic ingredients of Dang-Gui-Si-Ni decoction based on absorbed ingredients and molecular docking